Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.
about
Immunologic Changes Implicated in the Pathogenesis of Focal Segmental GlomerulosclerosisGlomerular diseases: FSGS.Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study designComparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.Limitations and future treatment options in type 2 diabetes with renal impairment.Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.Mitochondrial dysfunction in the pathophysiology of renal diseases.Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis.Peroxisome proliferator activating receptor-γ and the podocyte.Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?
P2860
Q26753833-D85BBD38-0D1D-4B38-B087-F19C48B53914Q27687257-E1836B33-A048-4A68-979B-8ACA366E32F8Q33817568-3A123FC4-B3B0-43BB-A7AE-E2F2F790BE83Q35188070-F51767D9-B51E-488C-9FE4-01F4FDE6D7DDQ36783886-3EAE9816-B896-4D20-80B3-F0D1D323A668Q37217446-BE679447-0184-4871-A648-F28014EE65C0Q37812564-7192C851-9458-470F-B481-920188805C94Q38085054-51BC6499-9811-44A4-9263-3CDE83DE451AQ38168664-55CC1ECB-D66B-4E5F-8EF6-BB79EA04CDF1Q38738516-30FDA2FA-1C97-4478-90BE-6BECEFA4CB77Q38815188-30CF7306-C9EB-43A9-9261-83D0F46EC7E7Q51066095-9BBD57C2-DDA1-4340-981A-7398C6FE04DD
P2860
Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Follow-up of phase I trial of ...... eport of the FONT study group.
@ast
Follow-up of phase I trial of ...... eport of the FONT study group.
@en
Follow-up of phase I trial of ...... eport of the FONT study group.
@nl
type
label
Follow-up of phase I trial of ...... eport of the FONT study group.
@ast
Follow-up of phase I trial of ...... eport of the FONT study group.
@en
Follow-up of phase I trial of ...... eport of the FONT study group.
@nl
prefLabel
Follow-up of phase I trial of ...... eport of the FONT study group.
@ast
Follow-up of phase I trial of ...... eport of the FONT study group.
@en
Follow-up of phase I trial of ...... eport of the FONT study group.
@nl
P2093
P2860
P356
P1433
P1476
Follow-up of phase I trial of ...... eport of the FONT study group.
@en
P2093
Alexandra Peyser
Cynthia Pan
Freya Tarapore
Jacqueline Machardy
Leslie Powell
Nathaniel Machardy
Suzanne Vento
Theresa Kump
Virginia Savin
P2860
P2888
P356
10.1186/1471-2369-11-2
P577
2010-01-29T00:00:00Z
P5875
P6179
1044642473